Eli Lilly (NYSE: LLY) sells treatments for a wide variety of therapeutic areas, but one portfolio in particular has driven ...

Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

There's no playbook for how to be competitive in artificial intelligence (AI) as a big pharma company, but Eli Lilly (NYSE: ...

Clea Shearer, star of the Netflix show “Get Organized with The Home Edit,” discussed her breast cancer journey after ...

Eli Lilly’s senior VP of information and R&D IT, Ramesh Durvasula, said Lilly will use AI and tech to transform the company.

A major trial is coming to Greater Manchester to see how a new drug can tackle obesity. The ‘five-year real-world evidence study’ will be run by Health Innovation Manchester and pharmaceutical giant ...

The U.K. will study whether Lilly's weight loss drug can get people back to work and help tackle long-term sickness ...

Severe malnutrition is treated with ready-to-use therapeutic food, a paste combining peanuts, sugar, milk powder, oil, ...

Effective treatment with dupilumab may allow younger children with severe atopic dermatitis and short stature to catch up on ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...